✦ LIBER ✦

2.244 PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF OPICAPONE, A NOVEL COMT INHIBITOR, DURING FIRST ADMINISTRATION TO HEALTHY MALE SUBJECTS

✍ Scribed by T. Nunes; J.F. Rocha; R. Pinto; R. Machado; L.C. Wright; A. Falcao; L. Almeida; P. Soares-da-Silva

Book ID: 117754937
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 18
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(11)70568-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.245 PHARMACOKINETICS, PHARMACODYNAMICS

2.245 PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF OPICAPONE, A NOVEL COMT INHIBITOR, DURING MULTIPLE RISING DOSE REGIMENS IN HEALTHY MALE SUBJECTS

✍ J.F. Rocha; T. Nunes; M. Vaz-da-Silva; R. Machado; L.C. Wright; A. Falcao; L. Al 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Pharmacokinetics, Pharmacodynamics and T

Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects

✍ Luis Almeida, José Francisco Rocha, Amílcar Falcão, P. Nuno Palma, Ana I. Lourei 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 699 KB

The pharmacokinetics, pharmacodynamics a

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

✍ Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dietmar Gansser; Willy Roth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects

✍ Ulf G. Eriksson; Ulf Bredberg; Kristina Gislén; Linda C. Johansson; Lars Frison; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 291 KB

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

✍ Ronald Christopher; Paul Covington; Michael Davenport; Penny Fleck; Qais A. Mekk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Integrated pharmacokinetics and pharmaco

Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans*

✍ Dingemanse, Jasper; Jorga, Karin M.; Schmitt, Monique; Gieschke, Ronald; Fottele 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 908 KB

Object&z-To assess the tolerability, pharmacokinetics and pharmacodynamics of single oral doses of the novel catechol-0-methyltransferase (COMT) inhibitor tolcapone in healthy volunteers. Metbuuk In this double-blind, placebo-controlled, ascending-single-dose study, doses of 5 to 800 mg tolcapone w